Development
Predictive Oncology Inc.
POAI
$0.9386
-$0.0114-1.20%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 19.37% | -14.66% | 56.77% | -95.00% | 60.93% |
| Total Depreciation and Amortization | -9.49% | -24.30% | -28.49% | 0.54% | 1.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.05% | 1,031.03% | -99.44% | 3,196.03% | -98.47% |
| Change in Net Operating Assets | -249.75% | 77.02% | -137.93% | -23.44% | 283.80% |
| Cash from Operations | 13.13% | -4.27% | -5.96% | -19.46% | 18.78% |
| Capital Expenditure | 98.47% | -946.72% | 57.93% | 54.79% | 31.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 83.41% | -298.21% | 63.40% | -- |
| Cash from Investing | 98.49% | -456.01% | 26.73% | 55.74% | 23.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -490.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -490.00% | -100.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.69% | -10.33% | -4.58% | -16.34% | -191.12% |